Standard BioTools Inc LAB

Technology Scientific & Technical Instruments

Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. The Company's segments include Proteomics and Genomics. The Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. The Company provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. It works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories around the world, focusing on the needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company also provides differentiated multi-omics tools for research.

NDAQ:LAB - Post by User

Standard BioTools Inc

<< Previous

Bullboard Posts

Next >>

Post by Humaniston May 14, 2021 11:57am

130 Views

Post# 33203649

FLDM ON A SPREE OF PRESENTAITON MAY 25/26/JUNE 2 CONFS

Fluidigm to Present at Upcoming Investor Conferences

5/14/2021 8:30 AM ET • GlobeNewswire

Fluidigm to Present at Upcoming Investor Conferences GlobeNewswire

SOUTH SAN FRANCISCO, Calif., May 14, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will participate in several upcoming investor conferences and provide updates on the company’s business strategy and growth plans.

UBS Global Healthcare Virtual Conference
Tuesday, May 25, 2021
Fireside chat presentation at 2:00 p.m. ET

Oppenheimer MedTech, Tools & Diagnostics Summit
Wednesday, May 26, 2021
Pre-recorded presentation made available the day of the conference

Jefferies Virtual Healthcare Conference
Wednesday, June 2, 2021
Fireside chat presentation at 3:00 p.m. ET

Webcasts of the live presentations can be accessed via the investor relations section of the Fluidigm® website at Events & Presentations. For those unable to participate in the live events, the webcasts will also be archived on the Fluidigm Investor Relations page at investors.fluidigm.com.

About Fluidigm
Fluidigm (Nasdaq:FLDM) focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, we develop, manufacture, and market multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Our customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, we strive to increase the quality of life for all. For more information, visit fluidigm.com.